Role of positron emission tomography in lymphoma

被引：90

作者：

Juweid, ME ^{[1
]}

Cheson, BD

机构：

[1] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA

[2] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA

[3] Georgetown Univ Hosp, Dept Internal Med, Washington, DC 20007 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 21期

关键词：

D O I：

10.1200/JCO.2005.01.904

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：4577 / 4580

页数：4

相关论文

共 24 条

[21] Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma:: Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
Spaepen, K
Stroobants, S
Dupont, P
Van Steenweghen, S
Thomas, J
Vandenberghe, P
Vanuytsel, L
Bormans, G
Balzarini, J
De Wolf-Peeters, C
Mortelmans, L
Verhoef, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 414 - 419
[22] Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
Spaepen, K
Stroobants, S
Dupont, P
Vandenberghe, P
Thomas, J
de Groot, T
Balzarini, J
De Wolf-Peeters, C
Mortelmans, L
Verhoef, G
[J]. ANNALS OF ONCOLOGY, 2002, 13 (09) : 1356 - 1363
[23] Wagner M, 2003, CANCER RES, V63, P2681
[24] Yap CS, 2003, J NUCL MED, V44, p189P